/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Repros Therapeutics Inc. (RPRX) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 0.84\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n -0.02\n\n (-2.33%)\n\n \n\n \n\n \n\n \n\n Volume: 94.78 k\n\n \n\n \n\n\n\n 10:36 AM EST Feb 10, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
February 10,2009
\n \n
Close: \n 10.3569\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
December 21,2009
\n \n
Close: \n 0.6415\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
0.84
\n 		\n\n \n \n \n
Change $
\n \n 0.02\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 2.33%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
0.84
\n 		\n \n \n \n\n
Bid Size
4200
\n 		\n \n \n \n
Ask
0.8458
\n\n 		\n \n \n \n
Ask Size
200
\n
\n \n \n \n
Open
0.86
\n 		\n \n \n \n
High
0.86
\n 		\n\n \n \n \n
Low
0.83
\n 		\n \n\n \n \n
Prev Close
0.86
\n
\n \n\n \n \n
Last Trade
10:36
\n 		\n \n \n \n
Volume
94.78 k
\n 		\n \n \n \n
\n
52 Wk Hi
10.3569
\n 		\n\n \n \n \n
52 Wk Low
0.6415
\n
\n \n\n \n \n
Market Cap
21.45 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
25,538,598
\n 		\n \n \n \n
EPS (TTM)
-2.07
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Small Caps (NSC)
\n
\n
\n
\n
\n
\n \n
Exchange
NSC
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Repros Therapeutics Inc.\n\n \n\n  (RPRX) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for RPRX\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Feb 08, 2010
\n\n \n\n\n\n
6:30 AM\n\n\n\n Repros Submits Response to FDA Regarding Androxal(R) Indication for Treatment of Hypogonadal Men Wishing to Preserve Fertility - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Feb 02, 2010
\n\n \n\n\n\n
6:30 AM\n\n\n\n Repros' New IND for the Investigation of Androxal(R) in the Treatment of Type II Diabetes in Men with Secondary Hypogonadism is Now Effective - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 29, 2010
\n\n \n\n\n\n
6:55 AM\n\n\n\n Biopharmaceutical Stock Alert for Repros Therapeutics Inc. Issued by InvestorSoup - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 28, 2010
\n\n \n\n\n\n
9:02 AM\n\n\n\n Skymark Research Initiates Independent Research Coverage on Repros Therapeutics Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 27, 2010
\n\n \n\n\n\n
1:01 PM\n\n\n\n Repros Receives Guidance from FDA Regarding Continued Development of Androxal(R) in Hypogonadal Men - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 15, 2010
\n\n \n\n\n\n
2:15 PM\n\n\n\n Repros Approved for Trading on Nasdaq Capital Market - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jan 11, 2010
\n\n \n\n\n\n
10:00 AM\n\n\n\n Repros Shelf Registrations of Stock Are Effective - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Dec 21, 2009
\n\n \n\n\n\n
6:30 AM\n\n\n\n Repros Awaits NASDAQ Ruling Regarding Delisting Appeal - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 12, 2009
\n\n \n\n\n\n
2:49 PM\n\n\n\n Repros Appoints Dr. Jaye Thompson to Board of Directors - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 09, 2009
\n\n \n\n\n\n
8:01 PM\n\n\n\n Repros to Appeal NASDAQ Delisting Notice - Business Wire
6:00 AM\n\n\n\n Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 02, 2009
\n\n \n\n\n\n
5:42 AM\n\n\n\n Fundamental and Technical Research for TKC, ACH, TEC, NAL, CTB and RPRX Posted on BenchmarkJournal.com Today - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 30, 2009
\n\n \n\n\n\n
6:59 AM\n\n\n\n Repros Therapeutics Announces Settlement with Major Creditors - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Oct 28, 2009
\n\n \n\n\n\n
8:01 PM\n\n\n\n Repros Therapeutics Announces Amendment of NIH Proellex(R) License - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 08, 2009
\n\n \n\n\n\n
9:45 AM\n\n\n\n Repros Therapeutics Inc. Announces Financing - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Oct 07, 2009
\n\n \n\n\n\n
12:23 PM\n\n\n\n Beacon Equity Issues Trading Overview for Repros Therapeutics Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Oct 06, 2009
\n\n \n\n\n\n
9:00 PM\n\n\n\n Repros Reports Androxal(R) Restores Normal Sperm Counts While Increasing Testosterone Levels in Hypogonadal Men - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Sep 29, 2009
\n\n \n\n\n\n
6:30 AM\n\n\n\n Repros Therapeutics Inc. Provides Update on Proellex - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Sep 25, 2009
\n\n \n\n\n\n
8:31 PM\n\n\n\n Glancy Binkow & Goldberg LLP, Representing Shareholders of Repros Therapeutics Inc., Announces There are 11 Days Remaining to Move for Appointment as Lead Plaintiff -- RPRX - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Sep 21, 2009
\n\n \n\n\n\n
8:30 AM\n\n\n\n Market Pulse Breaking News Alert for Monday, September 21, 2009: ARYC - Arrayit Corporation Wins Equipment Contract From Prestigious Sandia National Laboratories! - Marketwire
\n\n More News for RPRX >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");